Open Mic: Next in Health series - Paving the way for human science in preclinical testing скачать в хорошем качестве

Open Mic: Next in Health series - Paving the way for human science in preclinical testing

Many thanks to everyone who joined us for our latest Open Mic | Next in Health session — an inspiring conversation on how bioconvergence and next-generation in vitro models are transforming preclinical science! Here are some of the key insights shared during the discussion on moving from animal models to human-relevant technologies: ✔️ Human-like biology, deeper insight: Advanced in vitro systems such as organoids and microphysiological models are enabling more accurate predictions of human responses in early drug development. ✔️ Overcoming barriers to adoption: While organoids offer powerful biological relevance, consistency, scalability and workflow integration remain challenges — and automation, bioengineering and AI are helping bridge the gap. ✔️ Regulatory momentum is growing: Regulators are beginning to recognize these innovative approaches, opening the door to broader use of human-relevant models across the preclinical pipeline. 🙏 A huge thank you to our expert panel for sharing their perspectives and experiences: Gilles Weder, Head Research & BD, Life Science Technologies, CSEM Anne Moisan, Discovery Area Leader, Nephrology, Roche Dominic Hoepfner, Functional Genomics Group, Novartis Biomedical Research Jan Lichtenberg, CEO, InSphero AG 👉 Don’t miss the next Open Mic — sign up here to get your invitation: https://www.dayone.swiss/news-sign-up/ This event is organized by DayOne and hosted at the Switzerland Innovation Park Basel Area. Many thanks to Novartis for sponsoring the inspiring venue and networking Apéro.